Pulmonx Corporation provided revenue guidance for the third quarter ended September 30, 2023. The company's total worldwide revenue for the third quarter of 2023 is anticipated to be approximately $17.6 million, representing growth of approximately 30% over the same quarter last year.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.58 USD | -4.13% | -5.08% | -32.63% |
05-01 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
05-01 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.63% | 347M | |
+75.36% | 12.54B | |
-23.02% | 7.71B | |
+8.10% | 6.72B | |
+12.49% | 5.38B | |
+37.02% | 4.89B | |
-15.74% | 4.71B | |
-25.08% | 3.75B | |
-27.30% | 2.77B | |
+50.23% | 2.55B |
- Stock Market
- Equities
- LUNG Stock
- News Pulmonx Corporation
- Pulmonx Corporation Provides Revenue Guidance for the Third Quarter Ended September 30, 2023